Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Seattle › NPI 1306992151
Hospital

Swedish Health Services

Swedish Health Services was paid $125.52M by Medicaid between Jan 2018 and Dec 2024, across 573 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 12% of everything it billed.

33Billing provider infoSWEDISH HEALTH SERVICES
SEATTLE, WA 98122
33aNPI1306992151assigned 01/26/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$125.52M
24GClaims3,130,079
24DCodes billed573
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#2 of 49
Median peer was paid$20.06M
This provider vs. median6.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018440,193$18.13M
2019466,151$19.50M
2020396,416$16.30M
2021497,645$20.36M
2022475,215$19.12M
2023454,675$17.38M
2024incomplete399,784$14.73M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 12% 49,534 40,819 $15.42M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 115,736 107,666 $13.55M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.6% 91,896 84,596 $8.25M
J9271 Injection, pembrolizumab, 1 mg 6.3% 2,006 1,488 $7.90M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 5.9% 114,067 77,667 $7.45M
77412 4.2% 14,108 1,410 $5.28M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.1% 63,117 58,594 $5.16M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 17,758 17,002 $3.22M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2.0% 10,024 7,242 $2.47M
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.9% 28,073 26,251 $2.44M
J9263 Injection, oxaliplatin, 0.5 mg 1.9% 2,941 913 $2.41M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 23,157 18,104 $2.17M
561 more codes
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.7% 5,711 $2.10M
J2350 Injection, ocrelizumab, 1 mg 1.6% 210 $2.03M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.5% 22,745 $1.90M
70450 Computed tomography, head or brain; without contrast material 1.5% 13,406 $1.87M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 15,549 $1.70M
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1.3% 1,373 $1.58M
J2323 Injection, natalizumab, 1 mg 1.2% 705 $1.48M
45380 Colonoscopy, flexible; with biopsy, single or multiple 1.1% 4,512 $1.40M
96415 1.1% 7,743 $1.36M
59025 Fetal non-stress test <1% 8,629 $1.24M
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 10,131 $1.23M
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 2,454 $1.14M
J2505 Injection, pegfilgrastim, 6 mg <1% 705 $1.09M
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg <1% 826 $1.06M
J9355 Injection, trastuzumab, excludes biosimilar, 10 mg <1% 999 $1.03M
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 5,779 $1.01M
71275 Computed tomographic angiography, chest, with contrast material <1% 5,596 $984K
J9035 Injection, bevacizumab, 10 mg <1% 662 $789K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 8,620 $772K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 20,609 $727K
10060 <1% 3,374 $704K
90870 <1% 2,185 $557K
J2469 Injection, palonosetron hcl, 25 mcg <1% 8,551 $556K
96416 <1% 2,632 $549K
12001 <1% 2,587 $537K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 10,352 $521K
80053 Comprehensive metabolic panel <1% 121,503 $518K
J9306 Injection, pertuzumab, 1 mg <1% 378 $496K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 1,169 $472K
76642 <1% 5,622 $467K
76830 Ultrasound, transvaginal <1% 5,656 $466K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 5,873 $466K
Q5114 Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg <1% 317 $463K
76801 <1% 8,150 $419K
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg <1% 1,932 $403K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 6,797 $403K
87631 <1% 5,470 $394K
12011 <1% 1,663 $377K
93970 <1% 3,639 $362K
J1950 Injection, leuprolide acetate (for depot suspension), per 3.75 mg <1% 204 $353K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 6,462 $349K
70498 <1% 3,360 $343K
96367 <1% 5,868 $332K
77067 Screening mammography, bilateral, including computer-aided detection <1% 7,970 $321K
76770 <1% 2,490 $319K
J1453 Injection, fosaprepitant, 1 mg <1% 3,852 $301K
70496 <1% 3,365 $283K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,329 $279K
10061 <1% 1,524 $275K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,952 $274K
12002 <1% 1,396 $269K
77334 <1% 1,861 $253K
G0378 Hospital observation service, per hour <1% 21,082 $246K
77336 <1% 4,839 $243K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,131 $240K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 5,331 $239K
93971 <1% 2,522 $228K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 3,863 $217K
Q5120 Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg <1% 135 $210K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 7,143 $193K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 7,911 $191K
70491 <1% 1,334 $186K
J9395 Injection, fulvestrant, 25 mg <1% 635 $185K
80047 <1% 49,111 $177K
84484 <1% 42,043 $174K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 1,052 $172K
76818 <1% 5,968 $170K
36430 <1% 2,257 $166K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 7,605 $165K
19083 <1% 261 $157K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 14,856 $147K
J1756 Injection, iron sucrose, 1 mg <1% 4,789 $136K
J0185 Injection, aprepitant, 1 mg <1% 1,719 $132K
64400 <1% 465 $131K
43235 <1% 377 $128K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 16,042 $125K
77290 <1% 586 $122K
77065 Tomosynthesis, mammo <1% 3,874 $117K
83605 <1% 22,678 $117K
80048 Basic metabolic panel (calcium, ionized) <1% 26,850 $115K
93978 <1% 2,561 $114K
76870 <1% 1,247 $112K
29125 <1% 915 $109K
77066 Tomosynthesis, mammo <1% 3,797 $109K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 1,980 $108K
J9217 Leuprolide acetate (for depot suspension), 7.5 mg <1% 446 $107K
80076 <1% 31,153 $106K
77295 <1% 255 $102K
77386 <1% 379 $101K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 8,917 $97K
64483 <1% 220 $88K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,874 $88K
J9312 Injection, rituximab, 10 mg <1% 31 $87K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 2,768 $87K
71046 Radiologic examination, chest; 2 views <1% 17,962 $86K
90715 <1% 4,525 $85K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 693 $82K
93976 <1% 1,674 $79K
J9206 Injection, irinotecan, 20 mg <1% 975 $78K
36561 <1% 85 $78K
36415 Collection of venous blood by venipuncture <1% 41,917 $78K
70486 <1% 2,364 $78K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 64,772 $74K
77063 Screening digital breast tomosynthesis, bilateral <1% 5,373 $71K
87040 <1% 11,634 $69K
76819 Fetal biophysical profile; without non-stress testing <1% 1,703 $69K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 181,739 $67K
77470 <1% 102 $65K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,178 $63K
77280 <1% 376 $58K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,710 $56K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,890 $54K
87400 <1% 3,850 $53K
84145 <1% 6,368 $51K
74174 <1% 557 $48K
86300 <1% 4,699 $46K
97162 <1% 1,697 $46K
96523 <1% 1,381 $46K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 53,354 $46K
83880 <1% 10,044 $45K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 30,254 $45K
76813 <1% 1,384 $44K
J0897 Injection, denosumab, 1 mg <1% 350 $44K
36591 <1% 7,874 $43K
77300 <1% 969 $43K
76820 <1% 1,647 $42K
85379 <1% 8,353 $41K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,996 $41K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 2,572 $40K
76536 <1% 449 $37K
J1750 Injection, iron dextran, 50 mg <1% 812 $37K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 5,355 $37K
73630 <1% 5,856 $34K
73562 <1% 3,366 $33K
54161 <1% 71 $32K
97161 <1% 1,025 $32K
44970 <1% 13 $32K
71045 Radiologic examination, chest; single view <1% 28,550 $32K
72125 Computed tomography, cervical spine; without contrast material <1% 3,709 $32K
73610 <1% 6,116 $31K
47562 <1% 12 $28K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 285 $27K
82105 <1% 2,838 $26K
J3489 Injection, zoledronic acid, 1 mg <1% 946 $24K
84443 Thyroid stimulating hormone (TSH) <1% 11,784 $24K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,028 $24K
77331 <1% 425 $23K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,205 $23K
73030 <1% 4,695 $23K
72100 <1% 3,443 $22K
71250 <1% 615 $22K
73700 <1% 358 $22K
97535 Self-care/home management training, each 15 minutes <1% 2,251 $22K
J2997 Injection, alteplase recombinant, 1 mg <1% 572 $22K
73130 <1% 4,608 $21K
82784 <1% 4,221 $21K
93975 <1% 268 $21K
88307 <1% 1,625 $20K
82728 <1% 7,383 $20K
97116 <1% 2,401 $19K
80197 <1% 2,668 $19K
87158 <1% 1,659 $18K
91200 <1% 205 $18K
70487 <1% 87 $17K
64493 <1% 33 $17K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 573 $17K
97166 <1% 836 $17K
19081 <1% 24 $17K
76937 <1% 587 $17K
97165 <1% 671 $17K
85027 <1% 16,527 $17K
43264 <1% 46 $17K
83735 <1% 17,523 $17K
96375 Therapeutic injection; each additional sequential IV push <1% 63,183 $16K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 85 $16K
77001 <1% 191 $16K
82378 <1% 6,124 $16K
74018 <1% 2,820 $16K
73502 <1% 2,643 $15K
86304 <1% 2,393 $15K
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram <1% 97 $15K
77387 <1% 2,438 $14K
96368 <1% 3,593 $14K
74183 <1% 64 $14K
90686 <1% 1,291 $14K
86923 <1% 1,567 $13K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,996 $13K
J0515 Injection, benztropine mesylate, per 1 mg <1% 362 $13K
J9070 Cyclophosphamide, 100 mg <1% 170 $13K
73701 <1% 65 $13K
J0485 Injection, belatacept, 1 mg <1% 277 $12K
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg <1% 70 $12K
73110 <1% 3,609 $12K
76882 <1% 162 $12K
87517 <1% 755 $12K
87522 Neg quan hep c or qual rna <1% 776 $11K
86317 <1% 1,354 $10K
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg <1% 32 $10K
88185 <1% 442 $10K
85610 <1% 23,112 $10K
72040 <1% 926 $9K
73564 <1% 2,938 $9K
82607 <1% 2,849 $9K
87486 <1% 1,210 $9K
87581 <1% 1,210 $9K
83883 <1% 1,724 $8K
87641 <1% 1,564 $8K
96402 <1% 2,912 $8K
80061 Lipid panel <1% 1,755 $8K
84703 <1% 36,709 $8K
84702 <1% 9,914 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 55,189 $8K
72141 <1% 67 $8K
73140 <1% 2,633 $8K
82962 <1% 31,111 $7K
80050 General health panel <1% 1,581 $7K
72158 <1% 75 $7K
87507 <1% 110 $7K
87799 <1% 990 $7K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,150 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 11,256 $7K
84100 <1% 7,761 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 18 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 8,859 $6K
83540 <1% 6,533 $6K
81001 <1% 34,001 $6K
12013 <1% 38 $6K
96409 <1% 558 $6K
73080 <1% 2,171 $6K
87086 Culture, bacterial; quantitative colony count, urine <1% 14,142 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 3,605 $6K
73590 <1% 2,063 $6K
83690 <1% 42,492 $6K
96376 <1% 16,817 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,138 $6K
82570 <1% 5,653 $6K
86140 <1% 13,740 $6K
81003 <1% 46,159 $6K
86301 <1% 607 $6K
94060 <1% 104 $5K
97163 <1% 159 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 5,734 $5K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 91 $5K
71101 <1% 1,799 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 33,104 $5K
80143 <1% 495 $5K
82553 <1% 633 $4K
82565 <1% 4,312 $4K
36593 <1% 156 $4K
84156 <1% 5,619 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,328 $4K
86803 <1% 1,999 $4K
0001A <1% 164 $4K
62323 <1% 12 $4K
99195 <1% 102 $4K
83970 <1% 349 $4K
84466 <1% 2,392 $4K
72072 <1% 492 $4K
84439 <1% 3,786 $4K
C1781 Mesh (implantable) <1% 65 $4K
86850 <1% 5,484 $4K
20610 <1% 26 $4K
C1769 Guide wire <1% 3,176 $4K
94729 <1% 159 $4K
72131 <1% 109 $3K
10160 <1% 16 $3K
20553 <1% 63 $3K
74330 <1% 27 $3K
76942 <1% 57 $3K
83615 <1% 6,944 $3K
86901 <1% 8,920 $3K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 134 $3K
86900 <1% 7,430 $3K
80305 <1% 10,561 $3K
83521 <1% 604 $3K
84165 <1% 2,116 $3K
62369 <1% 116 $3K
80179 <1% 2,436 $3K
96417 <1% 6,647 $2K
73090 <1% 1,234 $2K
87340 <1% 2,939 $2K
84153 <1% 717 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 8,895 $2K
82746 <1% 1,789 $2K
J0640 Injection, leucovorin calcium, per 50 mg <1% 2,983 $2K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 54 $2K
96401 <1% 274 $2K
36000 <1% 1,514 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 34,903 $2K
85014 <1% 3,963 $2K
83550 <1% 2,482 $2K
94726 <1% 71 $2K
87081 <1% 3,009 $2K
82075 <1% 3,107 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 32,481 $2K
73660 <1% 469 $2K
88184 <1% 481 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 22,072 $2K
97035 <1% 276 $2K
87593 <1% 37 $2K
87210 <1% 6,310 $2K
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 209 $2K
87640 <1% 465 $1K
82803 <1% 7,958 $1K
84550 <1% 3,671 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 922 $1K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,770 $1K
86592 <1% 1,357 $1K
82550 <1% 3,373 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 11,915 $1K
J7030 Infusion, normal saline solution , 1000 cc <1% 20,749 $1K
87205 <1% 5,875 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,680 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 15,410 $1K
99152 <1% 2,161 $1K
87186 <1% 4,929 $1K
86704 <1% 1,710 $1K
J2704 Injection, propofol, 10 mg <1% 20,422 $1K
J2060 Injection, lorazepam, 2 mg <1% 10,331 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,039 $1K
87070 <1% 4,812 $1K
J3490 Unclassified drugs <1% 4,542 $1K
77332 <1% 26 $1K
72050 <1% 129 $1K
85730 <1% 5,397 $1K
87653 <1% 340 $1K
72170 <1% 299 $997.17
86780 <1% 505 $970.64
85651 <1% 5,198 $933.48
80069 <1% 277 $915.19
J3010 Injection, fentanyl citrate, 0.1 mg <1% 27,191 $882.72
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 16,775 $879.74
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 14,144 $879.48
86334 <1% 305 $868.95
74019 <1% 206 $865.40
87497 <1% 115 $862.45
85652 <1% 2,870 $843.51
94770 <1% 12 $841.86
84163 <1% 70 $818.70
77080 <1% 14 $803.18
73560 <1% 183 $783.66
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 15,689 $737.14
J2270 Injection, morphine sulfate, up to 10 mg <1% 13,539 $734.10
77417 <1% 727 $733.95
88342 <1% 2,624 $728.99
89051 <1% 695 $705.81
74220 <1% 28 $700.94
86480 <1% 86 $695.03
73552 <1% 165 $686.71
87902 <1% 27 $670.73
C1726 Catheter, balloon dilatation, non-vascular <1% 537 $653.19
80051 <1% 625 $610.18
83010 <1% 104 $605.27
86038 <1% 464 $601.34
G0379 Direct admission of patient for hospital observation care <1% 128 $579.68
99153 Mod sedat endo service >5yrs <1% 3,158 $559.86
82248 <1% 1,226 $555.00
J9171 Injection, docetaxel, 1 mg <1% 17 $529.92
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg <1% 85 $517.97
82150 <1% 2,868 $497.98
86706 <1% 477 $484.31
0031A <1% 15 $484.29
88341 <1% 1,082 $478.75
J0780 Injection, prochlorperazine, up to 10 mg <1% 4,321 $471.86
73100 <1% 15 $449.00
A4648 Tissue marker, implantable, any type, each <1% 1,271 $415.23
90656 <1% 51 $400.81
87075 <1% 2,340 $384.56
87150 <1% 629 $377.84
73060 <1% 108 $376.25
82077 <1% 981 $364.36
J9045 Injection, carboplatin, 50 mg <1% 2,663 $362.51
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 848 $361.83
J9267 Injection, paclitaxel, 1 mg <1% 3,108 $359.94
91322 <1% 30 $351.65
87077 <1% 1,838 $340.85
91320 <1% 36 $339.20
84403 <1% 68 $337.31
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,051 $336.62
85018 <1% 913 $326.95
87430 <1% 1,679 $320.30
86762 <1% 192 $310.78
84132 <1% 1,760 $309.17
G0008 Administration of influenza virus vaccine <1% 332 $298.47
J3475 Injection, magnesium sulfate, per 500 mg <1% 4,754 $285.54
J7120 Ringers lactate infusion, up to 1000 cc <1% 16,935 $268.04
88304 <1% 1,401 $267.09
A9270 Non-covered item or service <1% 27,429 $266.26
82533 <1% 55 $266.21
A9585 Injection, gadobutrol, 0.1 ml <1% 2,863 $262.19
86308 <1% 841 $262.06
87188 <1% 1,148 $258.24
81025 <1% 3,374 $249.09
84520 <1% 783 $248.95
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 4,235 $244.33
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 1,300 $241.77
J7050 Infusion, normal saline solution, 250 cc <1% 22,360 $241.65
96411 <1% 3,939 $236.25
87147 <1% 1,198 $234.19
86708 <1% 303 $234.05
86336 <1% 84 $233.25
74175 <1% 13 $227.29
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion <1% 51 $218.68
85045 <1% 400 $215.11
80074 <1% 67 $211.82
84450 <1% 768 $207.00
80202 <1% 32 $206.62
70360 <1% 40 $204.02
84155 <1% 757 $201.70
85046 <1% 660 $200.44
C2617 Stent, non-coronary, temporary, without delivery system <1% 559 $196.65
C9113 Injection, pantoprazole sodium, per vial <1% 3,576 $183.37
J1815 Injection, insulin, per 5 units <1% 5,381 $180.32
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 3,263 $175.74
83516 <1% 81 $170.10
82330 <1% 205 $163.51
74022 <1% 243 $162.43
85049 <1% 552 $155.24
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 6,313 $154.19
87073 <1% 13 $150.20
72220 <1% 13 $147.51
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 1,384 $143.55
87807 <1% 440 $142.31
84460 <1% 715 $139.20
86644 <1% 95 $138.17
80178 <1% 18 $135.60
87493 <1% 26 $129.60
99406 <1% 244 $129.41
82525 <1% 101 $128.03
J1644 Injection, heparin sodium, per 1000 units <1% 8,859 $120.10
J3370 Injection, vancomycin hcl, 500 mg <1% 5,717 $115.22
87116 <1% 15 $114.85
83021 <1% 12 $113.57
82140 <1% 212 $113.08
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 1,983 $112.16
90480 <1% 58 $111.57
82010 <1% 528 $110.53
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 6,354 $110.32
87481 <1% 261 $109.76
73070 <1% 26 $99.00
J2560 Injection, phenobarbital sodium, up to 120 mg <1% 262 $96.18
36592 <1% 27 $91.96
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 1,128 $87.26
J1940 Injection, furosemide, up to 20 mg <1% 1,414 $86.71
84481 <1% 53 $80.74
82670 <1% 12 $78.13
J3480 Injection, potassium chloride, per 2 meq <1% 3,491 $76.02
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 227 $75.08
88311 <1% 45 $74.36
85384 <1% 157 $71.58
86787 <1% 69 $70.82
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 6,248 $68.56
88313 <1% 91 $67.95
C1729 Catheter, drainage <1% 334 $57.06
85660 <1% 39 $54.24
82310 <1% 56 $53.42
J9000 Injection, doxorubicin hydrochloride, 10 mg <1% 232 $51.23
J1650 Injection, enoxaparin sodium, 10 mg <1% 8,124 $50.95
C1788 Port, indwelling (implantable) <1% 84 $48.66
97026 <1% 47 $46.98
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,260 $45.92
0353U <1% 686 $42.70
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 413 $40.45
J2550 Injection, promethazine hcl, up to 50 mg <1% 591 $35.04
83001 <1% 13 $33.58
J8540 Dexamethasone, oral, 0.25 mg <1% 1,560 $32.66
82247 <1% 14 $26.95
88312 <1% 54 $26.38
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 711 $25.44
J1790 Injection, droperidol, up to 5 mg <1% 2,127 $25.39
82947 <1% 129 $24.69
86665 <1% 16 $23.88
87071 <1% 102 $23.11
94761 <1% 504 $22.91
J3411 Injection, thiamine hcl, 100 mg <1% 1,736 $22.89
82950 <1% 36 $21.57
82043 <1% 13 $20.09
88112 <1% 93 $18.96
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 749 $18.05
J1630 Injection, haloperidol, up to 5 mg <1% 1,928 $17.68
85007 <1% 62 $16.75
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 34,253 $15.34
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 3,741 $14.84
86735 <1% 16 $12.21
86765 <1% 16 $12.21
J7060 5% dextrose/water (500 ml = 1 unit) <1% 3,801 $11.22
J9190 Injection, fluorouracil, 500 mg <1% 5,642 $11.20
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 1,111 $9.84
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml <1% 142 $8.42
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 123 $8.38
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 1,907 $7.30
85670 <1% 12 $5.61
J3360 Injection, diazepam, up to 5 mg <1% 461 $5.30
84295 <1% 62 $3.81
J1171 Injection, hydromorphone, 0.1 mg <1% 423 $3.50
86905 <1% 17 $3.19
J1836 Injection, metronidazole, 10 mg <1% 698 $3.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 575 $1.46
J1956 Injection, levofloxacin, 250 mg <1% 338 $1.42
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 249 $1.00
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 297 $0.41
J0692 Injection, cefepime hydrochloride, 500 mg <1% 1,420 $0.24
J0461 Injection, atropine sulfate, 0.01 mg <1% 824 $0.20
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 509 $0.17
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 852 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 261 $0.00
0240U 0% 15 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 448 $0.00
J7999 Compounded drug, not otherwise classified 0% 892 $0.00
97814 0% 47 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 328 $0.00
J0456 Injection, azithromycin, 500 mg 0% 198 $0.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 0% 194 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 247 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 305 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 153 $0.00
89060 0% 12 $0.00
J1597 Injection, glycopyrrolate (glyrx-pf), 0.1 mg 0% 82 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 134 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 281 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 39 $0.00
87206 0% 15 $0.00
C9463 Injection, aprepitant, 1 mg 0% 22 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 42 $0.00
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries 0% 13 $0.00
87154 0% 25 $0.00
85008 0% 27 $0.00
C9399 Unclassified drugs or biologicals 0% 65 $0.00
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 13 $0.00
51798 0% 15 $0.00
96377 0% 17 $0.00
G8991 Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
91303 0% 14 $0.00
91035 0% 12 $0.00
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 0% 238 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 718 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 1,328 $0.00
88360 0% 41 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 506 $0.00
51702 0% 136 $0.00
J2359 Injection, olanzapine, 0.5 mg 0% 190 $0.00
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 0% 55 $0.00
J0670 Injection, mepivacaine hydrochloride, per 10 ml 0% 39 $0.00
97813 0% 47 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 12 $0.00
G8989 Self care functional limitation, discharge status, at discharge from therapy or to end reporting 0% 13 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 783 $0.00
G2215 Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure 0% 27 $0.00
96549 0% 229 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 30 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 202 $0.00
88333 0% 14 $0.00
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries 0% 81 $0.00
C1776 Joint device (implantable) 0% 155 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 71 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 187 $0.00
88173 0% 50 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 0% 28 $0.00
29515 0% 26 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 21 $0.00
90653 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASSISTANT SECREATRY FOR ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.